A COMBINED PHASE 2/3 12-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY INVESTIGATING THE EFFICACY OF AMT-101 IN SUBJECTS WITH CHRONIC ANTIBIOTIC-RESISTANT POUCHITIS

Registry ID

AMT-101-201

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE2

Study type

INTERVENTIONAL

Sponsor

APPLIED MOLECULAR TRANSPORT INC.

Start date

2021-10-26

Last update

2020-05-19

Conditions

• POUCHITIS

View on source registry